It's the biggest money making MACHINE in the pharma sector with an insanely low p/e, incredible growth, 93% gross margins and 40+% net margins and no debt. Oh, I forgot almost a $million revenue per employee and over $1.5 million per rep (with well over 100 NEW REPS).
A p/e under 10 and a forward p/e of about 5 makes this the buy of the decade!!! Shorts and bears can say what they want, but these are irrefutable FACTS!!!